HLS:CC News and Press, HLS Therapeutics Inc. From 11/09/23

K-Bro Linen Inc. (KBL:CA) is expected to report $0.57 for Q3 2023 Yellow Pages Limited (Y:CA) is expected to report for Q3 2023 Ascot Resources Ltd. (AOT:CA) is expected to report for Q3 2023 Park Lawn Corporation (PLC:CA) is expected to report $0.27 for Q3 2023 Hut 8 Mining Corp....

HLS Therapeutics Inc. (HLS:CA) is expected to report $-0.16 for Q3 2023

HLS Therapeutics to Host Q3 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Oct. 26, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q3 Fiscal 2023 financial results on Thur...

HLS Therapeutics to Present at H.C. Wainwright's 25th Annual Global Investment Conference Canada NewsWire TORONTO , Sept. 6, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS"...

HLS Therapeutics Announces Q2 Fiscal 2023 Financial Results Canada NewsWire TORONTO , Aug. 10, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular mark...

HLS Therapeutics to Host Q2 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , Aug. 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q2 Fiscal 2023 financial results on Thursday, ...

HLS Therapeutics Announces Updates to its Board of Directors Canada NewsWire John Welborn, Jr. is appointed Chair of the Board, succeeding Greg Gubitz , who is retiring John Hanna is appointed to the HLS Board as an independent director ...

HLS Therapeutics Announces Agreement with Polar Asset Management Partners and Retirement of Two Directors from the Board of Directors Canada NewsWire HLS Directors J. Spencer Lanthier and Don DeGolyer will not be standing for re-election at the 2023 AGM ...

HLS Therapeutics Announces Q1 Fiscal 2023 Financial Results Canada NewsWire TORONTO , May 11, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), a pharmaceutical company focusing on central nervous system ("CNS") and cardiovascular markets, a...

HLS Therapeutics to Host Q1 Fiscal 2023 Financial Results Conference Call Canada NewsWire TORONTO , May 3, 2023 /CNW/ - HLS Therapeutics Inc. ("HLS" or the "Company") (TSX: HLS), announces that it will release its Q1 Fiscal 2023 financial results on Thursday, M...